NCT03336515 (POSTURAL) is a NA clinical trial of Group C-Postural device activated in OSA, sponsored by Hospital Universitario Araba.

Who is sponsoring NCT03336515?

NCT03336515 is sponsored by Hospital Universitario Araba.

What drugs are being tested in NCT03336515?

Interventions in NCT03336515: Group C-Postural device activated, Group B-Postural device no activated, Group A-General Recommendation.

Is NCT03336515 still recruiting?

NCT03336515 is currently completed. Last updated 3 October 2019.

Last reviewed 2019-10-03 · How we verify

NCT03336515: POSTURAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)

Completed NA Last updated 3 October 2019

What this trial tests

NA trial testing Group C-Postural device activated in OSA in 128 participants. Completed in 27 July 2018.

Timeline

1 September 2015

Primary endpoint
27 April 2018

27 July 2018

Quick facts

Lead sponsor	Hospital Universitario Araba
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	128
Start date	1 September 2015
Primary completion	27 April 2018
Estimated completion	27 July 2018
Sites	1 location across Spain

Drugs / interventions tested

Group C-Postural device activated
Group B-Postural device no activated
Group A-General Recommendation

Conditions studied

OSA — all drugs for OSA →

Sponsor

Hospital Universitario Araba

Who can join

18 and older, any sex, with OSA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is validity of the effectiveness of a vibrating postural device in reduce the respiratory events (Apnea-Hypopnea Index-AHI) in patients with positional Obstructive Sleep Apnea (OSA).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Positional therapy for obstructive sleep apnoea.
Srijithesh PR, Aghoram R, Goel A, Dhanya J. · · 2019 · cited 40× · PMID 31041813 · DOI 10.1002/14651858.cd010990.pub2
New forehead device in positional obstructive sleep apnoea: a randomised clinical trial.
Hidalgo Armas L, Ingles S, Vaca R, Cordero-Guevara J, et al · · 2021 · cited 8× · PMID 33888576 · DOI 10.1136/thoraxjnl-2020-216167
Patient compliance and satisfaction with a new forehead device for positional obstructive sleep apnoea treatment: a post hoc analysis of a randomised controlled trial.
Hidalgo-Armas L, Inglés S, Vaca R, Cordero-Guevara J, et al · · 2023 · cited 1× · PMID 37349132 · DOI 10.1136/bmjresp-2022-001503

Verify or expand the search:

Other recruiting trials for OSA

Currently open trials in the same condition.

NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
NCT06110962 — Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor · recruiting
NCT06591169 — Lifestyle Changes in PCOS with OSA and NAFLD · NA · recruiting
NCT06091098 — Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA · NA · recruiting

Other Hospital Universitario Araba trials

Trials by the same sponsor.

NCT05066581 — Vitoria Sleep Smart City: Interactive Intervention for Sleep Improvement · NA · completed
NCT03868046 — Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC) · completed
NCT04206449 — Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA) · NA · completed
NCT03449550 — Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03336515 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Araba
Last refreshed: 3 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03336515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing